鉴定体质突变驱动增强剂及其在乳腺癌中的临床实用性
Hongying Zhao1, Ke Feng1, Junjie Lei2
1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
iScience
|February 2, 2024
概括
乳腺癌的体质突变改变了增强剂的活性,影响了预后. 这些增强剂和向药物为乳腺癌 (BRCA) 亚型提供了潜在的新疗法策略.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 身体突变是癌症发展的关键驱动因素.
- 增强剂在调节基因表达方面起着至关重要的作用,并且可以通过突变改变.
- 了解乳腺癌中增强剂的改变对于确定新的治疗点至关重要.
研究的目的:
- 确定与乳腺癌风险和预后相关的突变驱动增强剂.
- 研究特定增强器突变对乳腺癌亚型的影响.
- 发现针对这些突变增强剂的潜在治疗药物.
主要方法:
- 根据乳腺癌 (BRCA) 中的染色质可访问性变化,确定了135种基因突变驱动增强剂.
- 分析增强子突变作为BRCA亚型 (Her2和正常) 的独立预后因素.
- 在体中进行药物选,以确定针对突变增强剂的候选药物.
主要成果:
- 135个突变驱动增强剂被确定为潜在的BRCA风险因素.
- 发现四种增强剂是BRCA亚型的独立预后因素.
- 特定增强剂突变 (Her2中的G>C,正常亚型中的G>A) 与预后较差有关.
- 已确定针对不同BRCA亚型的突变增强剂的候选药物.
结论:
- 身体突变改变了增强剂的活性,导致乳腺癌亚型的进展.
- 由突变驱动的增强剂代表了乳腺癌的潜在治疗标.
- 针对性药物治疗可以基于BRCA中的特定增强因子突变来开发.
更多相关视频
06:29Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland
Published on: June 7, 2019
12.8K
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
7.6K
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
